Search

Periprosthetic fractures can occur both intraoperatively and postoperatively with implantation of cementless tapered stems.In a large cohort of patients receiving cementless, proximally hydroxyapatite-coated femoral implants, we answered the following questions: What was the incidence of intraoperative and postoperative fractures associated with the implant? What were the fracture patterns as classified by the Vancouver classification system? Did the Vancouver classification represent the fracture patterns found? How were the fractures treated and what were the treatment outcomes; that is, how many fractures healed and did the stems osseointegrate?We evaluated 1039 hips (932 patients) from three prospective studies. The hips were divided into three groups: no fractures, intraoperative fractures, and postoperative fractures. Demographic differences among the groups were noted. Postoperative fractures were classified using the Vancouver classification system. We judged stem stability using Engh's criteria and fracture union was determined by the treating surgeon and confirmed by the authors.We identified 58 periprosthetic fractures in the 1039 hips (5.6%): 38 intraoperative (3.7%) and 20 postoperative (1.9%). Eleven of the postoperative fractures were classifiable by the original Vancouver classification system and nine were of the newly described "clamshell" variety, not classifiable by this system. No intraoperative fractures extended below the lesser trochanter. Twenty-five of these fractures were treated with a single cable or cerclage wire. The remaining received no specific treatment. Of the 20 postoperative fractures, five were treated nonoperatively. All stems osseointegrated.Both intraoperative and postoperative fractures can be managed with success when the stem is stabilized or found to be osseointegrated. An adjustment to the Vancouver classification is suggested to include the clamshell fracture, which has not been previously described.

Introduction: To investigate a long-term in vivo deterioration of polymethylmethacrylate (PMMA) bone cement over time, we evaluated retrieved PMMA cement in terms of chemical elements presenting in the cement using energy dispersive analysis of X-rays; Knoop hardness; and the Young’s modulus using scanning acoustic microscopy. Materials and Methods: For mechanical evaluation, we could neglect the influences of entrapped air bubbles or blood by the use of small specimens. The study was based on thirteen cement samples (six used in the acetabulum and seven in the femur) derived from eight patients (age at revision surgery: mean 72.5, range 68 to 79). All of these samples were Simplex-P?cement. They were functioning well at least ten years after the previous surgery. Duration until revision surgery was ranged 12 to 25 years (average, 17.4 years). The reason for revision was aseptic mechanical loosening. Twenty samples of Simplex-Preg; cement were served by manually mixing as a control. Results: The average of the hardness of the cement was 17.0 ± 1.2 (range, 13.4-20.6). In the control, the hardness was 17.8 ± 1.5 (range, 14.0-24.6). There was no significant difference between these values. The mean of Young’s modulus of the cement was 5.61 ± 0.19 GPa (range, 5.09-6.10). In the control, the modulus was 6.04 ± 0.13 GPa (range, 5.68-6.45). Although the modulus was significantly less than that of the control, there was only 7% decrease in average between twelve and twenty-five years in vivo. Conclusions: Our results suggest that long-term implantation and functional loading in vivo may not be the limiting factor in the mechanical integrity of the bone cement.

Compared with conventional polyethylene, first-generation highly cross-linked polyethylenes have low wear, but controversy exists regarding their reduced mechanical strength and/or retained free radicals. Second-generation highly cross-linked polyethylenes have been developed to reduce wear, maintain mechanical strength, and have oxidative resistance, but it is unclear whether they do so.The primary objective of this study therefore was to determine if a second-generation annealed material has low linear wear at 5 years followup. Secondary objectives were to evaluate for overall survivorship, implant fixation, osteolysis, and effect of socket inclination on wear.In a multicenter prospective study, we radiographically evaluated 155 patients (167 hips) at 3 years, 124 patients (132 hips) at 4 years, and 46 patients (51 hips) at 5 years. The linear head penetration rate was measured at 6 weeks, 1 year, and yearly through 5 years.The head penetration per year after the first year of bedding-in was 0.024 mm per year at 3 years, 0.020 mm per year at 4 years, and 0.008 mm per year at 5 years. The average wear rate over 5 years was 0.015 mm per year and represents a 58% improvement over a first-generation annealed highly cross-linked polyethylene. The Kaplan-Meier survivorship (revision for any reason) was 97.8%. We revised no hip for bearing surface failure and observed no osteolysis. Socket inclination did not affect linear wear.These data suggest the linear wear rate for a second-generation annealed highly cross-linked polyethylene is no greater than that for historic controls of first-generation highly cross-linked polyethylenes, and no untoward complications were encountered with this new material.Level II, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.

Ceramic bearings were introduced to reduce wear and increase long-term survivorship of total hip arthroplasty. In a previous study comparing ceramic with metal-on-polyethylene at 5 to 8 years, we found higher survivorship and no osteolysis for the ceramic bearings.We asked whether ceramic bearings have equal or superior survivorship compared with that for metal-on-polyethylene at longer followup; we also determined survivorship of the implant systems, the presence or absence of radiographic osteolysis, and incidence of device squeaking.Five surgeons at five sites have followed 189 patients (216 hips) for a minimum of 10 years and average of 10.3 years (range, 10-12.4 years) comparing alumina ceramic bearings (144 hips) with cobalt chrome-on-polyethylene bearings (72 hips). We determined Kaplan-Meier survivorship of the bearing surface and implant systems and collected radiographic and clinical data.We observed no difference between the control metal-on-polyethylene and the alumina-bearing couple cohorts with regard to bearing-related failures (98.9% versus 99.1%). Revisions for any reason occurred in 10.5% of the control patients and 3.1% of the patients with alumina bearings. All femoral implants remain well fixed (100%), whereas one acetabular component (1%) is unstable in the control group. Osteolysis occurred in 26% of the control patients and in none of the patients with alumina bearings. Squeaking occurred in two of 144 hips (1.4%) of the patients with ceramic bearings.Patients receiving the ceramic-on-ceramic bearings had fewer revisions for any reason and less osteolysis than the control metal-on-polyethylene at 10 years. Our data suggest ceramic bearings continue to provide an option for the young and more active patient and provide for a measure to compare other new alternative bearings that are currently available.Level I, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

Highly cross-linked polyethylene (HXLPE), created by disrupting the molecular structure of polyethylene, then through the application of heat, encourages creation of new cross-links in the process, resulting in a material with improved wear resistance. The impetuses for this new technology were the unsatisfactory wear properties and subsequent osteolysis of noncross-linked polyethylene. A 72% reduction in wear using highly cross-linked polyethylenes (HXLPE) compared with conventional polyethylene at 5 years was described previously. The longest term followup studies on HXLPE range from 2 to 6 years. We therefore addressed the following questions: (1) Does the improvement in wear observed at the earlier followup continue to 7 to 10 years? (2) What is the incidence of osteolysis in this group of patients and in the control group? We retrospectively reviewed 38 prospectively followed patients who had 42 hips with an annealed HXLPE who were followed a minimum of 7 years (average, 8.6 years; SD = 1; range, 7–10.3 years). Wear and osteolysis were compared with those of a control group of 39 patients (40 hips) from a US Investigational Device Exemption (IDE) prospective, randomized study begun in 1996 with conventional polyethylene and followed for a minimum of 6 years (average, 7.5 years; SD = 1.1; range, 6–10.2 years). Linear head penetration was measured from AP radiographs at early, 1-year, 5-year, and most recent followups. At the average followup, annual linear wear was 0.031 mm (SD = 0.014) for the HXLPE and 0.141 mm (SD = 0.080) for the control group, a 78% reduction. No mechanical failure of the polyethylene was noted in either group. Incidence of osteolysis was 50% in the control group (all lesions confined to proximal Gruen Zones 1 and 7) compared with no cases in the investigational group. We observed an improvement in wear and no mechanical failures with this annealed material. Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

This study reports revision and complication rates of a single cementless double-wedged tapered stem with an alumina-alumina bearing over 10 years since the beginning of premarket clinical trials. Of 930 hips (848 patients) implanted by 9 surgeons, there were 19 revisions at mean follow-up of 5.9 years compared to 10 revisions in the 123 hips implanted with the polyethylene control group at mean 7.8 years. The ongoing safety of alumina-alumina bearings is demonstrated through excellent (96.8%) survivorship at 10 years. Twenty-one patients reported 23 incidences of noise described as clicking, squeaking, popping, or creaking. Eight patients with 9 hips described the noise as squeaking, most occurring rarely and only 1 occurring frequently in a patient subsequently revised for a reason aside from the squeaking.

This prospective, randomized, multicenter study of alumina ceramic–on–alumina ceramic bearing couples includes 452 patients (475 hips). Their average age was 53 years with approximately two thirds men and 82% with osteoarthritis. At an average 8-year follow-up, clinical results were excellent and cortical erosions significantly less than in the conventional polyethylene-on-metal bearing group. Nine hips have undergone revision of one or both components for any reason. Of the 380 ceramic liners, 2 (0.5%) have fractured requiring reoperation, and 3 (0.8%) ceramic patients reported a transient squeaking sound, one of which had a head and liner change due to groin pain secondary to psoas tendinitis at 5 years. With no revisions for aseptic loosening and minimal cortical erosions, alumina-ceramic bearing couples are performing in a manner superior to the polyethylene-on-metal bearing in this young, active patient population.

Total hip replacement (THR) requires revision in only a minority of cases (approximately 17% of prosthetic hips fail), but when THR failures occur there may be significant acetabular bone deficiency. There is a variety of surgical hardware and strategies available to address this problem. The causes of primary THR revision include aseptic loosening or particle disease, infection, recurrent dislocation, implant failure, periprosthetic fracture, and leg length discrepancy. Almost all patients who need THR revision undergo a standard radiographic evaluation of the pelvis and hip. In general, CT is an excellent tool for evaluating loosening of the prosthesis caused by either mechanical reasons or infection, and MR imaging is best suited for evaluating the soft tissues surrounding the prosthesis. Nuclear medicine studies are performed when results of CT and MR imaging are inconclusive. When patients are evaluated for revision THR, radiologists must check for acetabular cup loosening, the amount and type of bone stock loss, the amount of component migration, and the presence or absence of liner wear. Before revision hardware is placed, bone stock loss must be repaired, either by using bone grafting or by placing accessory acetabular hardware such as cups, rings, or cages. The long-term success of revision acetabular surgery varies; there is acetabular cup presence at 5 years after surgery in 60%-94% of cases. Complications include postoperative infections, repeat liner wear, bone graft failure, periprosthetic or prosthetic fractures, dislocation, vascular injury, and nerve injury.

A once annealed highly cross-linked polyethylene (HXLPE) was introduced in 1998. Concerns regarding its long-term performance and oxidative resistance exist because of the presence of retained free radicals. The authors studied 48 patients with 50 hip implants having an average age of 62 years. They were followed for 9 to 15 years. The purpose of this study was to determine linear wear rate and the incidence of osteolysis and/or mechanical failure. At an average follow-up of 12.2 years, the annual linear wear rate was 0.018 mm (SD, 0.024 mm). No mechanical failures or osteolysis have been found to date. The clinical performance of this HXLPE continues to meet expectations despite the presence of free radicals. [ Orthopedics. 2016; 39(3):e565–e571.]

Hydroxyapatite-coated femoral components were introduced to enhance fixation, but concerns were raised about whether the coating would be maintained over time. We therefore determined the long-term clinical and radiographic results of a proximally hydroxyapatite-coated femoral component and compared the mechanical failure rate to other fixation methods at similar lengths of followup. The study group, culled from a large, multicenter prospective study population, consisted of 146 patients (166 hips) with followup of 15 to 18 years. Average age at time of the index procedure was 51 years, and the most common diagnoses were osteoarthritis (71%) and osteonecrosis (11%). Average Harris hip scores were 42.7 preoperatively and 91.5 at most recent followup. Radiographically, one stem showed stable fibrous fixation, and all other unrevised stems were bony stable. Of 13 stem revisions in the study population, only one stem has been revised for aseptic loosening. Forty-nine percent of hips have an osteolytic lesion in proximal areas of Gruen Zones 1, 7, 8, or 14 only. Both the femoral aseptic revision and mechanical failure rates are 0.6% at 15-year minimum followup. The data demonstrate excellent long-term survivorship of this hydroxyapatite-coated femoral component used in a relatively young patient group.

Our objective is to describe the use of hydroxyapatite coatings in total hip arthroplasty. Hydroxyapatite enhances bone ingrowth and provides for a durable and lasting construct. The femoral component has performed well at 15-year minimum follow-up, with aseptic revision rates routinely less than 1%. Initial results on the acetabular side were disappointing. However, after redesign, a second-generation arc-deposited hydroxyapatite-coated cup is performing well at 4- to 7-year follow-up. Hydroxyapatite-coated implants have also been used successfully in the revision setting. Future applications include the use of hydroxyapatite coating as a means of delivering bone-enhancing drugs such as the bisphosphonates.

The introduction of multichannel CT scanners provides both radiologists and surgeons with a new tool to image patients with orthopedic hardware. The key parameters that have made it possible to image the implants and the surrounding bone with multichannel CT are the higher available technical factors (kVp and mAs) coupled with the ability to acquire thin slices over a large scan region. These properties make it possible to produce high-quality multiplanar reformations that facilitate visualization of the orthopedic device and the surrounding bone. An important consideration for multichannel CT imaging of hardware is the reduction of cone beam artifacts caused by the geometry of multichannel CT scanners. This artifact is reduced by using a narrower x-ray beam collimation and a low pitch setting. This article discusses CT scan parameters and image postprocessing used at our institution and illustrates common clinical problems encountered when imaging implanted orthopedic devices. These include fracture healing, loosening of joint prostheses, evaluation of particle disease, and the use of CT for preoperative planning in revision arthroplasty.

UNLABELLED We examined whether encasing the alumina ceramic total hip arthroplasty insert in a thin titanium sleeve would reduce significantly or eliminate insert chipping on impaction of the insert into the shell. We also compared results, including observations of osteolysis, of the Trident study group with those of the predecessor alumina bearing couple design to determine clinical improvement and radiographic stability. Beginning in October 1996, 328 alumina ceramic bearings were implanted by six surgeons in 316 patients as a part of a prospective, randomized United States Investigational Device Exemption three-arm study comparing an alumina ceramic bearing with a control bearing of cobalt-chromium on polyethylene. In September 1999, a fourth arm of the study (Trident) was added. The Trident insert was recessed within a thin titanium sleeve. At three to five years followup, osteolysis was found in 0% of the patients with the Trident insert and in 0.5% of the patients with an alumina bearing couple. At a mean followup of 4.2 years (range, 3-5 years) no ceramic chips, fractures, or ceramic bearing failures have occurred. Encasing the alumina ceramic insert in a titanium sleeve seems to have resolved the issue of insert chipping on impaction and supports the continued use of Trident bearings in relatively young patients. LEVEL OF EVIDENCE Therapeutic study, Level II-1 (prospective comparative study-patients treated one way compared with a group of patients treated in another way at the same institution). See the Guidelines for Authors for a complete description of levels of evidence.

UNLABELLED Three hundred twenty-eight ceramic bearings were implanted by six surgeons in 316 patients as a part of a prospective randomized US Investigational Device Exemption study comparing alumina ceramic bearings with cobalt chrome-on-polyethylene bearings. There was no difference between the control metal-on-polyethylene and the alumina bearing couple patient cohorts regarding demographics or clinical scores through 7 years. Revision for any reason occurred in 2.7% of the patients with alumina bearings and 7.5% of the control patients with polyethylene bearings. Osteolysis was found in 1.4% of the patients with alumina bearings and in 14.0% of the control patients. At an average followup of 5.0 years (range, 1-86 months) no ceramic fractures or ceramic bearing failures have occurred. Results of this study suggest that alumina ceramics perform as well as the metal-on-polyethylene in clinical scores, but the patients with ceramic bearings had fewer revisions and less osteolysis. These results lead us to think that this new alumina ceramic bearing provides a safe option for younger and more active patients. LEVEL OF EVIDENCE Therapeutic study, Level I-1b (randomized controlled trial, no significant difference, but narrow confidence intervals). See the Guidelines for Authors for a complete description of levels of evidence.

Alumina ceramic is an excellent material for biologic implantation. Decreased particulate wear debris should increase implant longevity. The purpose of this study is to examine clinical and radiological results of ceramic-on-ceramic hip implants compared to cobalt chrome on polyethylene. Four cementless systems were compared, three alumina-on-alumina bearing systems: System I, porous coated cup; System II, hydroxyapatite-coated cup; Trident system, hydroxyapatite-coated cup with metal sleeve backing on ceramic cup liner; and System III (control), porous-coated cup with polyethylene and cobalt chromium bearing system. Patients were randomized to receive System I, II, or III. Trident patients were not randomized. Examinations are performed at 6 months, 1 year and yearly thereafter including x-rays, clinical exam and Harris Hip Score (HHS). Minimum 24-month followup was performed in 562 ceramic hips and 154 control hips. Age, height, weight, gender and diagnosis were similar in all groups. HHS was rated good/excellent by 95 percent of ceramic hips and 97 percent of control hips. Radiographic results demonstrated radiolucency in Femoral Gruen Zone 1 in 3.8 percent (18/474) of ceramic hips and in 8 percent (10/128) of control hips. Unstable acetabular components were reported in none of ceramic hips and in 3.2 percent (5/154) of control hips. Revision was performed in 7 (1.2 percent) ceramic hips, none due to failure of ceramic materials, and in 9 (5.8 percent) control hips. Alumina ceramic materials show promise, but continued evaluation of long-term clinical results is needed.

A goat model of revision hip arthroplasty was used to examine the histology and mechanical performance of impaction grafting using two femoral stems varying in stem surface finish. There were no significant mechanical or qualitative histologic differences between smooth, tapered, polished stems and step-cut, grit-blasted stems. Allograft distribution, bone incorporation, and cement mantle thickness were not uniform within the femoral canal. Efforts to improve the impaction grafting technique may be more important than stem design.

Constrained acetabular components have been used to treat certain cases of intraoperative instability and postoperative dislocation after total hip arthroplasty. We report our experience with a tripolar constrained component used in these situations since 1988. The outcomes of the cases where this component was used were analyzed for component failure, component loosening, and osteolysis. At average 10-year followup, for cases treated for intraoperative instability (2 cases) or postoperative dislocation (4 cases), the component failure rate was 6% (6 of 101 hips in 5 patients). For cases where the constrained liner was cemented into a fixed cementless acetabular shell, the failure rate was 7% (2 of 31 hips in 2 patients) at 3.9-year average followup. Use of a constrained liner was not associated with an increased osteolysis or aseptic loosening rate. This tripolar constrained acetabular liner provided total hip arthroplasty construct stability in most cases in which it was used for intraoperative instability or postoperative dislocation.

Female patients under 45 years of age (average, 32.5; range, 14–44) at the time of primary bipolar or total hip arthroplasty (THA) were surveyed an average 10.5 years (range, 1.7 to 20.3 years) after the index procedure. Most patients were satisfied with the pain relief and functional abilities. Of the 109 respondents (137 hips), 37 (34%) had undergone 50 additional hip procedures. Thirteen women (12%) had 19 children at an average of 3 years after hip arthroplasty. Seven women had 1 child each; 6 had 2 children; and 1 had dizygotic twins. Eleven infants were delivered vaginally and 8 by cesarean section (5 planned, 3 unplanned). Two pregnancies were considered high risk unrelated to the hip arthroplasty. Pregnancy-related complications for these patients did not differ from those in the general population.

The short-term efficacy of using constrained acetabular components for hip instability in the total hip arthroplasty construct has been documented. However, long-term concerns including late dislocation, loosening of components, and osteolysis have not been addressed. The authors evaluated, at an average 10.3-year follow-up, 101 tripolar constrained components (Stryker Howmedica Osteonics) used in the total hip arthroplasty construct. At final follow-up, 6 hips had dislocated or had failure of the constrained component, 5 of which were revised. In addition, 4 hips were revised for aseptic loosening of the acetabular component, 4 hips were revised for aseptic femoral loosening, and 1 hip was revised for acetabular osteolysis. Considering the complexity of the cases, this component has provided durable fixation and hip stability at this intermediate-term follow-up.

We report the results of total hip arthroplasty with use of a proximally hydroxyapatite-coated femoral component after a minimum follow-up of ten years in a group of patients who were less than fifty years old at the time of the primary procedure. In the five years since the original publication of our study, two additional stems have undergone revision. Thus, a total of six stems have been revised. A small amount of erosive scalloping of the proximal part of the femur was seen in nearly one-half of the hips; however, all unrevised stems were radiographically stable and no hip had intramedullary osteolysis. The revision rate because of aseptic loosening of the stem was 0.9%, which compares favorably with that for other stems and other fixation methods in young patients at this point in time. This stem is currently being paired with a highly cross-linked polyethylene liner because of cup failures and the need for reoperation secondary to excessive polyethylene wear and proximal femoral osteolysis.

One hundred and two consecutive cemented femoral stems were evaluated in 92 patients at an average 9-year follow-up and a minimum 5-year follow-up (range, 5-14 years). The stem used was cobalt chromium with a collar, normalization steps, and a roughened surface (Ra 40); the stem was inserted using contemporary cementing techniques. This series demonstrated a femoral component aseptic loosening rate of 2.0% and a femoral component survivorship of 97.2 ± 2.0% at 10 years. One of 2 failed stems was revised at 95 months for failure at the cement-bone interface. The second failed stem showed failure at the cement-bone interface with incomplete debonding radiographically at 65 months. The remaining femoral components did not demonstrate any evidence of debonding at the stem-cement interface. These results compare favorably with other series of cemented femoral stems, as well as with those with a polished surface. © Elsevier Inc. All rights reserved.

We evaluated the clinical, radiographic, and survivorship outcomes in a series of 418 threaded hydroxyapatite-coated acetabular cups (Arc2f; Osteonics, Allendale, NJ) implanted in a consecutive series of 384 patients undergoing primary total hip arthroplasty. In all cases, the cup was screwed into the prepared acetabulum. Bone screws were used to provide secondary fixation. At a minimum 10-year follow-up, 304 cups were available for analysis. The cumulative survivorship (mechanical failure as endpoint) at that time was 99.43% ± 0.0104. Two hundred seventy-six hips were available for full clinical and radiographic review at or after the tenth anniversary. No unstable implants were noted; all implant fixation interfaces were classified as “stable bone ingrown,” and the cup migration rate was zero. Based on the survivorship achieved with this implant, our results compare favorably with survivorship reported for the best cemented and cementless acetabular implant designs. Copyright 2003, Elsevier Science (USA). All rights reserved.

This article presents an experience with alumina ceramic bearings involving the use of improved ceramic materials as well as new design considerations. The alumina-alumina ceramic hard bearing is a safe option for the younger, more active patient.

A primary aim of research in total hip arthroplasty is to extend longevity through improved fixation and decreased wear and osteolysis. Age range of patients receiving hip implants is ever increasing as technology improves and average life span increases. The current report focuses on minimum 10-year results of a proximally hydroxyapatite-coated stem in patients with degenerative joint disease, comparing those 45 years and older (n = 229 hips) with younger patients (n = 41 hips). Clinically, the average Harris hip score is 91 points and 88 points in the older and younger groups, respectively. Mechanical failure rates for the stem are 0.4% and 2.4%, with one stem revision for aseptic loosening and no radiographically loose stems in each age group. Proximal femoral osteolysis is seen more often in younger patients (48% versus 38%), and younger patients (six hip arthroplasties) had reoperation for wear or osteolysis. Therefore, this stem has performed well at a 10-year minimum followup. However, polyethylene wear and osteolysis have led the authors to begin a United States Food and Drug Administration study of an alumina ceramic-on-alumina ceramic bearing surface in conjunction with the same stem. At 2 years minimum followup, there have been no complications related to the ceramic bearing surfaces, no cortical erosions, and no stem revisions for aseptic loosening.

A major challenge for total hip arthroplasty is to minimize wear and osteolysis in young, active patients. Alumina ceramic bearings have shown superior wear resistance and lubrication and do not carry the risk of ion release. In a prospective randomized study, 514 hips were implanted. All patients (average age, 53 years) received the same press-fit hydroxyapatite coated femoral stem; two thirds (345 hips) received alumina ceramic bearings, and one third (169 hips) received a cobalt-chrome-on-polyethylene bearing. At a mean follow-up of 35.2 months (range, 24-48 months), there was no significant difference in clinical performance between the patient cohorts. No ceramic fracture or alumina ceramic bearing failure occurred. This new experience involves the use of improved ceramic materials and new design considerations that eliminate the risks and complications of past experiences with ceramic implants and provides a safe bearing option for young patients.

First-generation once annealed highly crosslinked polyethylene (HXLPE) has perfomed well for over 10 years but the presence of free radicals remain a concern. A second-generation sequentially annealed HXLPE was developed to further reduce wear, maintain mechanical strength, and enhance oxidative resistance.

Morphologic features of the hips, in particular those features germane to determination of acetabular and femoral anteversion angles and femoral head offset, were studied in 50 male and 50 female human skeletons with bilateral normal joints. Four distinct configurations were identified relative to t

Three hundred eighty hydroxyapatite-coated titanium alloy stems were implanted in a young and active patient population from 1987 through 1990. Within the population, 274 patients (314 hips) had a minimum 10-year and maximum 13-year followup. The average age of the population was 51 years. Thirty-seven percent of the population was 50 years or younger when operated on (average age, 39 years). Osteoarthritis was seen in 63.7% and avascular necrosis in 16.6% of patients. Fifty-four percent of patients were men. Clinically, these patients had early pain relief and rapid restoration of function. The Harris hip score averaged 92 points, and only 1.6% of patients had mild or moderate activity-related thigh pain. Radiographically, progressive remodeling occurred around the implants, 100% were bone stable, and no patient had endosteal distal osteolysis. Two patients had revision surgery for aseptic loosening: one at 2 years postoperative because of a nonunion of a concomitant subtrochanteric osteotomy and one at 9.5 years postoperative because of polyethylene wear and progressive osteolysis. The mechanical failure rate was 0.5%. The results show excellent lasting fixation of this tapered titanium alloy stem coated proximally with a thin, dense layer of hydroxyapatite. The stem has performed well in a young, active, high-risk population and in the hands of various surgeons.

Polyethylene wear is a major contributor to osteolysis and subsequent aseptic loosening of prosthetic components in total hip arthroplasty. Use of ion implantation as a surface modification to the metallic bearing component of orthopaedic implants may be an effective means of reducing wear debris at the bearing interface. In July 1991, low friction ion treated femoral heads were introduced. This study evaluates the effect of the low friction ion treated femoral head on polyethylene wear. Fifty-five total hip arthroplasties (53 patients) with low friction ion treated femoral heads followed up a minimum of 3 years were matched with 55 total hip arthroplasties (47 patients) without low friction ion treated femoral heads for the same postoperative period. Socket wear was evaluated radiographically. Case matching and strict inclusion criteria were used to control for known factors influencing polyethylene wear. These criteria included: (1) cases matched for gender and age within 2 years; (2) diagnosis limited to osteoarthritis or avascular necrosis of the femoral head only; (3) femoral head diameter limited to 26 or 28 mm only; (4) hydroxyapatite coated femoral stem of the same design and a metal backed socket of the one of two designs with the same polyethylene insert; and (5) minimum followup of 3 years. The linear wear rate of polyethylene was 0.161 +/- 0.095 mm per year in the group without the low friction ion treated heads and 0.116 +/- 0.101 mm per year in the low friction ion treated group. The volumetric wear rates were 74.5 +/- 44.3 mm3 per year for the group without the low friction ion treated heads and 57.8 +/- 51.1 mm3 per year for the low friction ion treated group. Assuming the sensitivity of these measurements can detect these small differences in wear accurately, these results suggest low friction ion treated prosthetic heads are useful in reducing polyethylene wear at 3-year minimum followup.

Seventy-six hips in 67 patients were evaluated an average of 119 months (range, 61-150 months) after total hip arthroplasty with porous coated Omnifit femoral and acetabular components. The patients were young (average age, 45 years), and most were male (67%). Two stems and one cup were revised for aseptic loosening, for aseptic revision rates of 2.6% on the femoral side and 1.3% on the acetabular side. Thigh pain was present in three cases, one of which was activity limiting. Twenty-five (35.7%) hips had evidence of osteolysis confined to proximal Gruen Zone 1 or 7 or to the acetabulum (22 proximal femoral, three both). There were no cases of intramedullary osteolysis in surviving stems. Thirteen (17.1%) hips have undergone reoperation for bone grafting of progressive proximal osteolysis without component revision, at an average 93 months after the total hip arthroplasty. At an average 40 months after reoperation, all stems remain well fixed, and there has been no recurrence of osteolysis of grafted femoral lesions. These results suggest that a circumferentially proximally porous coated femoral component in cementless total hip arthroplasty can provide stable fixation for as long as 12 years after implantation and can seal the canal from distal osteolysis. Serious concerns remain about the incidence of proximal femoral osteolysis.

Surgeons who perform arthroplasties have posed some critical questions about hydroxyapatite. Does hydroxyapatite coating enhance bone ingrowth or ongrowth? Will hydroxyapatite lead to increased polyethylene wear or an increased incidence of osteolysis? Will the hydroxyapatite coating disappear, and if so, what will be left to maintain implant fixation? A multicenter study of 316 hips (282 patients) with a proximally hydroxyapatite coated stem and either a hydroxyapatite or porous coated cup were followed up 8.1 years (range, 5.6-9.9 years). The average patient age was 50 years (range, 16-81 years), and 61% of the patients were male. One (0.3%) stem, three (2.7%) porous coated cups, and 25 (11.9%) hydroxyapatite coated cups were revised for aseptic loosening. Disappointing results on the acetabular side indicate that substrate design is critical. There were no cases of intramedullary femoral osteolysis, and the incidence of acetabular and proximal femoral osteolysis and polyethylene wear was no greater than that seen with other cementless or cemented components. Based on these clinical results and a critical review of the literature, it is concluded that hydroxyapatite coated hip components do enhance ingrowth or ongrowth with no increased incidence of osteolysis for as many as 10 years. Concern about the disappearance of the hydroxyapatite coating with time seems moot in light of the above clinical findings.

We evaluated 377 patients (428 hips) who had been managed, by a total of fourteen surgeons at twelve clinical sites in the United States and Europe, with a porous-coated press-fit acetabular cup, a hydroxyapatite-coated threaded screw-in cup, or one of two similar designs of hydroxyapatite-coated press-fit cups between April 1987 and November 1992. The same type of hydroxyapatite-coated femoral stem was inserted without cement in all patients. After a minimum duration of follow-up of five years (mean, 7.9 years; range, 5.3 to 9.1 years), one (1 per cent) of the 131 hydroxyapatite-coated threaded cups, two (2 per cent) of the 109 porous-coated press-fit cups, and twenty-one (11 per cent) of the 188 hydroxyapatite-coated press-fit cups had been revised because of aseptic loosening. A common radiographic sign of impending failure of the hydroxyapatite-coated press-fit cups was radiolucency at the interface between the implant and the subchondral bone beneath it. This radiolucency usually was seen initially more than two years after implantation. Radiographic evaluation of the 383 acetabular implants that were in situ at the time of the most recent follow-up showed that 123 (99 per cent) of the 124 hydroxyapatite-coated threaded cups, 101 (98 per cent) of the 103 porous-coated cups, and 139 (89 per cent) of the 156 hydroxyapatite-coated press-fit cups were stable with osseous ingrowth (as indicated by the absence of radiolucency at the interface and the absence of migration within the acetabulum). The probability of revision due to aseptic loosening was significantly greater for the hydroxyapatite-coated press-fit cups than it was for the hydroxyapatite-coated threaded cups or the porous-coated press-fit cups (p < 0.001 for both comparisons). Within the group of patients who had a hydroxyapatite-coated press-fit cup, the probability of revision due to aseptic loosening was significantly greater in association with a young age (p = 0.003), female gender (p = 0.02), the use of a femoral head with a diameter of thirty-two millimeters (p = 0.018), and the use of a thin polyethylene liner (p < 0.001). We found that the hydroxyapatite-coated threaded cups and the porous-coated press-fit cups continued to perform well more than five years after the operation. The hydroxyapatite-coated press-fit cups that were revised probably failed because the fixation interface beneath the cup could not sustain the tensile stresses that were imposed between the cup and the bone by the activity of the patient. Our data suggest that, in the specific biomechanical environment of the acetabulum, physical interlocking between the cup and the supporting bone beneath it may be a prerequisite for long-term stability.

One hundred and thirty-three patients (152 hips) who were an average of thirty-nine years old (range, sixteen to forty-nine years old) received a proximally hydroxyapatite-coated femoral prosthesis as part of a total hip arthroplasty and were followed for a minimum of five years (average, 6.4 years; range, five to 8.3 years) or until revision. The average Harris hip score was 47 points (range, 22 to 77 points) preoperatively and 93 points (range, 49 to 100 points) at the time of the latest clinical evaluation. Two patients who had a well fixed femoral implant had activity-limiting pain in the thigh at the time of the most recent examination. Radiographic changes consistent with bone-remodeling (cortical hypertrophy and bone condensation) typically were seen around the mid-part of the shaft of the prosthesis. Forty-eight (32 per cent) of the 148 hips that were included in the radiographic analysis demonstrated a small amount of erosive scalloping in either zone 1 or zone 7 of Gruen et al., and intramedullary osteolysis was suspected in only one hip. All stems were radiographically osseointegrated according to a modification of the criteria described by Engh et al. Four stems were revised, but none of the revisions were performed because of mechanical failure (two stems were revised in conjunction with a revision of the cup because of pain; one, because of an infection; and one, after a traumatic femoral fracture that occurred six years postoperatively). Thus, the rates of aseptic and mechanical failure were both 0 per cent. The combined rate of failure, which included the two stems that were revised because of pain and the two stems that were associated with pain that limited activity, was 2.6 per cent (four of 152 stems). The over-all clinical results associated with hydroxyapatite-coated femoral components were excellent in this group of young patients after intermediate-term follow-up. A review of serial radiographs showed mechanically stable implants with osseous ingrowth, evidence of stress transmission at the middle part of the stem, and minimum endosteal osteolysis.

Although ceramic-on-ceramic bearings for total hip arthroplasty (THA) show promising results in terms of bearing-surface wear, fracture of the bearing, insertional chips, and squeaking remain a concern.Our primary objective of this report was to determine overall survivorship of a titanium-encased ceramic-on-ceramic bearing couple. Our secondary objectives were to evaluate for ceramic fracture, insertional chips, osteolysis, and device squeaking.Six surgeons at six institutions implanted 194 patients (209 hips) with an average age of 52 years with cementless hips and alumina ceramic bearings. One hundred thirty-seven patients (146 hips) have 10-year followup (70%). We determined Kaplan-Meier survivorship of the bearing surface and implant system and collected radiographic and clinical data to evaluate for osteolysis and squeaking.Survivorship using revision for any reason as the end point was 97% at 10 years and survivorship end point bearing surface failure or aseptic loosening of 99%. There was one ceramic insert fracture (0.5%), there were no insertional chips, there was no visible osteolysis on AP and lateral radiographs, and there was a 1% patient-self-reported incidence of squeaking at the last clinical followup. Six hips underwent revision (3.7%).Ceramic bearings for THA with a titanium-encased insert have high survivorship at 10 years followup and a fracture risk of 0.5%. We found at last followup on routine radiographs no evidence of osteolysis, and no patient has been revised for squeaking or has reported dissatisfaction with the clinical result because of noise. IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

Two hundred and twenty-four total hip arthroplasties were performed in 201 patients with use of a femoral component with hydroxyapatite coating of the proximal portion of the stem. The mean duration of follow-up was seventy-one months (range, fifty-eight to eighty-seven months). Of the 224 arthroplasties, 208 (93 per cent; 190 patients) yielded a good or excellent clinical result. Four patients (2 per cent) reported mild-to-moderate activity-related pain in the thigh, and two (1 per cent) had aseptic loosening. The radiographic findings of progressive new-bone formation (cancellous condensation and cortical hypertrophy) throughout the zones adjacent to the middle and distal portions of the stem were evidence of early, extensive proximal fixation of the implant, with distal stress transfer through the implant, which is stiffer than the surrounding bone. Remodeling of the femur began early, was predictable, and progressed throughout the follow-up period. Cortical hypertrophy about the middle and distal portions of the stem occurred predominantly in the mediolateral plane (in 105 hips [47 per cent], compared with thirteen hips [6 per cent] in the anteroposterior plane), and it was more common in patients who had had poorer bone quality preoperatively. Intramedullary osteolysis was present in one femur (0.4 per cent) at five years; the osteolytic area was less than five millimeters in its greatest dimension and had not progressed at the time of the six-year follow-up evaluation. This low rate of osteolysis suggests that a circumferential coating of hydroxyapatite may effectively minimize migration of wear debris along the femoral stem. The progressive remodeling of the femur about the middle and distal portions of the stem, as evidenced by cancellous condensation and cortical hypertrophy, has not, to our knowledge, been described previously to this magnitude in association with proximally coated (porous or hydroxyapatite-coated) femoral implants.

Among complications of total joint arthroplasty, infection is of the most concern because it may be devastating and potentially lethal. The rate of prosthetic joint infection has remained relatively stable at 0.5% to 2.0%, 1,2 and most frequent organisms are Staphylococcus epidermidis and Staphylococcus aureus. 3 Fungal arthritis following joint replacement surgery is particularly rare with only 17 previous cases reported in the English language literature. 4-14 We describe three new cases of hip prostheses infected by Candida albicans. We expect that more such cases will be seen in the future, as immunosuppressed patients on steroids develop avascular necrosis of subarticular bone.

Total hip arthroplasty (THA) has been shown to be highly effective in ameliorating pain and increasing function in adults with end stage arthritis of the hip. Early studies of cemented THA in children with advanced hip disease reported poor results, but, more recently, results of cementless THA show greatly improved outcomes. More recently, concerns related to THA in children have focused on wear of the bearing surfaces, which may result in periprosthetic bone loss and eventual loosening of the prosthetic components. This case report describes the use of an alumina ceramic-on-alumina ceramic bearing surface in THA in a 13-year-old female with bilateral end-stage arthritis of the hips. At 7 and 8 years post-THA, the patient has no pain, no limp, and is able to walk long distances without difficulty. Radiographs show no signs of implant loosening, osteolysis, or wear of the bearing surface.

Reconstruction of the femur depends on the quantity of bone loss and the quality of the remaining bone stock. Multiple classifications and reporting systems can be used to characterize the bone defect. We present a simple algorithmic approach for proximal femoral bone loss reconstruction during revision total hip arthroplasty. Quantity of bone loss is assessed using radiographs based on different classification systems, whereas quality of the remaining bone stock is assessed intraoperatively. Based on the type of proximal bone loss and the quality of the available bone, we describe our preferred reconstruction technique. For minor bone loss, the metaphysis is expanded but intact with partially absent calcar. There is minimal bone loss anteriorly and posteriorly, and the diaphysis is intact. For significant bone loss, the metaphysis is compromised, and there is no calcar. There is minimal bone loss anteriorly and posteriorly. The available proximal bone may be thin, sclerotic, and incapable of support. However, the diaphysis is intact. For massive bone loss, there is complete circumferential bone loss in the metaphysis, extending to the diaphysis. The anterolateral bone and supporting subtrochanteric metaphyseal bone are absent. The metaphysis is not stable and will not offer rotational stability. There is massive bone loss anteriorly and posteriorly. The stability of the implant is dependent on distal diaphyseal fixation. For complete proximal bone loss, there is extensive circumferential segmental bone loss proximally and extensive cavitary loss involving the entire diaphysis. Additionally, there is extensive ectasia of the diaphysis.

The sensitivity of magnetic resonance (MR) imaging in the detection of avascular necrosis (AVN) of the hip and natural history of the MR findings were determined prospectively in renal allograft recipients, a group at risk for development of the disease. One hundred four patients were studied up to 24 months after transplantation. In 25 hips in 14 patients, MR findings were consistent with AVN. Pain developed in seven hips in four patients; in each hip, the MR images showed abnormality before the onset of symptoms. Plain radiographs showed abnormality in all hips that became painful; however, the plain radiographs of 17 of 18 asymptomatic hips in which MR imaging showed evidence of AVN showed no abnormality over a mean follow-up period of 16 months. All MR lesions in the symptomatic hips were larger than those in the asymptomatic cohort. MR lesions in seven hips (in five asymptomatic patients) regressed in size; in six hips, the MR images returned to normal. The findings suggest that some patients with MR evidence of AVN of the hip have spontaneous improvement.

Trochanteric nonunion associated with total hip arthroplasty (THA) may result from 1 of 3 situations: 1) isolated fracture of the greater trochanter; 2) complication of trochanteric osteotomy; or 3) fracture secondary to cystic formation or osteolysis from wear debris post-THA. Isolated fracture of the greater trochanter can occur during primary or revision THA or as a result of trauma in the post-THA patient. It is estimated that approximately 5% of intraoperative femoral fractures involve just the greater trochanter. Perhaps the most common case is subsequent to trochanteric osteotomy. Although trochanteric osteotomy is more often used in revision THA, it may be used in primary THA where there is severe femoral deformity, developmental dysplasia of the hip, or in cases where previous intraosseous hardware is removed. Finally, trochanteric nonunion may be seen in subsequent to late fracture through an osteolytic lesion of the greater trochanter. Regardless of the etiology, nonunion of the greater trochanter can result in significant pain, Trendelenberg gait, and functional limitations, and additional surgery to reattach the trochanter may be required. Reattachment may be accomplished using various techniques, including abductor slide, trochanteric claw plate, Dalls-Miles cable grip system, and various wiring techniques. The nonunion rate following trochanteric osteotomy ranges up to 6%, and persistent nonunion following reattachment ranges up to 39%.

Most bone remodeling is thought to occur within the first few years after THA. Loss of bone density later may be associated with stress shielding or normal bone loss of aging. We evaluated remodeling changes over time with a proximally hydroxyapatite-coated tapered titanium stem. We evaluated plain radiographs of 143 hips for cancellous condensation, cortical hypertrophy, cortical porosis, cortical index, and canal fill at early postoperative, 5, 10, and 15 years. Average age was 51 years at THA; 69 patients (77 hips) (53%) were women; and 102 hips (71%) had primary osteoarthrosis. Based on radiographic findings at 15 years, hips were divided into three subgroups: 43 (30%) demonstrated minimal remodeling changes; 53 (37%) demonstrated cortical hypertrophy evident before 5 years; and 47 (33%) demonstrated additional late remodeling and cortical porosis, most often after 10 years. Hips with poorer bone (Dorr Types B or C) and, when including only hips with osteoarthrosis, more female hips had cortical porosis at 15 years. Late radiographic changes in patients with porosis appear more similar to that associated with an extensively rather than proximally coated stem. Whether continued bone adaptation and bone loss of aging will eventually threaten implant stability is unknown, but at 15 years, all 143 implants remained well fixed and clinically asymptomatic. Level of Evidence: Level III, retrospective study. See the Guidelines for Authors for a complete description of levels of evidence.

Objective: To estimate the importance of center and provider effect and its implication on the estimation of treatment effect in surgical randomized controlled trials.Summary Background Data: Provider and center effect may play an important role in the estimated treatment effect of multicenter surgical randomized controlled trials (RCTs). However, such effects are rarely accounted for in surgical RCTs.Methods: Analysis of patient-level data from 3 large surgical randomized controlled trials. One trial in ophthalmology comparing retinal detachment rate after retinal reattachment in 225 patients operated on by 32 providers across 10 centers; one trial in orthopaedics comparing Harris Hip Score after total hip replacement in 496 patients operated on by 22 providers across 18 centers; one trial in general surgery comparing recurrence rate of hernia repair in 200 patients operated on by 88 providers across I I centers. A provider effect and a center effect were searched for by comparing nonadjusted and adjusted models. An analysis of volume (ie, number of procedures performed during the course of the trial) effect and, when relevant, a treatment-by-volume interaction was also sought.Results: A significant provider effect was found in ophthalmology (P Conclusions: Provider and center effects play a significant role in the estimation of treatment effect of large randomized controlled surgical trials. Not accounting for such effects may lead to biased estimates and misleading conclusions. These effects should be accounted for in the design and analysis of such trials.

Wear debris from metal-on-polyethylene articulation in conventional total hip arthroplasty can limit the implant's longevity. Modern ceramic material with high wear resistance and low fracture risk has the potential to extend the lifetime of total hip arthroplasty, which makes the procedure potentially more suitable for young, active patients. Concerns with brittle ceramic material include fracture risk, the "squeak" phenomenon, and potentially a higher dislocation rate secondary to limited neck lengths and liner options. We therefore determined the early dislocation rate in modern ceramic-on-ceramic total hip arthroplasty. In 1635 total hip arthroplasties performed over the 9-year period (1996-2005), we observed three anterior and 15 posterior dislocations (1.1%). All were treated successfully, one with a revision and 17 with closed reduction under general anesthesia. Ceramic-on-ceramic total hip arthroplasty can be a good alternative bearing surface with a low dislocation rate.

Osteolysis resulting from polyethylene wear debris is one of the most common causes of implant failure in young, active individuais who undergo total hip arthroplasty. Reducing wear may help extend implant life in younger, more active patients. Contemporary alumina ceramic/alumina ceramic bearing articulations are harder, are scratch resistant, and are more hydrophilic than other bearing couples. This results in reduced wear and reduction of particle load to the surrounding tissue. Therefore, bearings made of alumina ceramic may be a preferable bearing choice for younger, more active patients.

Surface replacement (SR) was introduced as a bone-conserving alternative to total hip arthroplasty (THA) 3 decades ago, then was abandoned due to polyethylene wear, stress shielding, and loosening. Improved bearing surfaces have renewed interest in SR. This study examined long-term SR outcome compared to an age- and time-matched THA cohort. Average age was 47 years at index procedure with 16 years follow-up (range, 5-28). Revision rates were 86% and 40% in SR and THA groups, respectively. However, at 20 years, with an end point of either intact SR or primary THA in the SR group, survivorship was 64% +/- 6% versus 39% +/- 7% unrevised in THA cohort. Contemporary and rapidly changing technology may result in longer-term SR success and improved THA longevity in young patients.

AIDS has created considerable concern among the public regarding being transfused with potentially infectious blood. However, autologous blood donations are still not maximally provided nor utilized. Significant heart disease disqualifies all allogeneic and most autologous blood donors (American Association of Blood Banks (AABB) Standards 1994). Disqualification is based on the widespread belief that donating blood could possibly be detrimental to their health. However, this belief has not been sufficiently documented. Sixty-eight donors (ages 14-84 years), all with histories of significant cardiac diseases, donated 111 units of whole blood (1-3 units). Twenty-eight patients donated 1 unit, 37 donated 2 units, and three patients donated 3 units. Fifty-nine patients had ischemic heart disease, and nine had valvular heart disease (five with mitral stenosis and four with mitral valve prolapse). No patient received erythropoietin, and only one received equal volume replacement with normal saline during donation. All these patients eagerly wished to donate in spite of being informed of the possible complications. No patient wishing to donate has been refused, and none has experienced any adverse consequences from donating. Forty-four patients underwent total hip/knee replacements. Only 56 units (50%) were transfused to 37 patients (54%). Although our experience is limited, it appears that many patients with histories of well established cardiac diseases can easily tolerate donating blood without compromising their health.